
My name is Alex Sevko
I am passionate about understanding why cancer patients respond to therapy and how scientific evidence can be translated into smarter drug development decisions.
With more than 20 years of experience spanning academia and biotechnology, I specialise in advancing immuno-oncology through translational research, biomarker strategy and clinical development.
I have worked across organisations including DKFZ, Adaptimmune, Prokarium, Infinitopes, and Amphista,
helping teams connect disease biology, drug mechanism and patient heterogeneity to generate actionable translational insights.
Ultimately, my goal is to help teams make better-informed development decisions, accelerate clinical success and improve outcomes for patients.
Beyond consulting, I am passionate about mentoring scientists and supporting the next generation of translational medicine and biomarker professionals.

Doctor of Philosophy (PhD) in Biological Sciences (Oncology)
RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology (IEPOR), National Academy of Sciences of Ukraine, Kyiv, Ukraine, 2004
Bachelor of Science (Honors) in Biology – Specialization: Biologist-Cytologist, Histologist, Biology of Individual Development
Taras Shevchenko National University of Kyiv, Kyiv, Ukraine, 1999
Specialization in Clinical Laboratory Diagnostics
National Medical Academy of Post-Graduate Education Named After P.L. Shupik, Kyiv, Ukraine, 2005
Diploma, Doctor’s Assistant – Specialization in Clinical Laboratory Diagnostics
First Medical Specialized School, Kyiv, Ukraine, 1992

HCPC (Health and Care Professions Council) – Registered Biomedical Scientist
IBMS (Institute of Biomedical Science) – Fellow member
EACR (European Association for Cancer Research) – Professional Member
CIMT (Cancer Immunotherapy Consortium) – Professional Member
TMed Networking Group (Translational Medicine Networking Group) – Member
Resilient Collective (a platform that is designed to connect companies with highly skilled independent consultants) – Member